2022

  • 2022 Academic and Teaching Awards

    June 10, 2022
    The Department of Oncology presented its five 2021-2022 awards for outstanding academic and teaching at its recent Research & Education Day. Four recipients are members of the CTCR namely: Saman Maleki, PhD (Experimental Oncology), Dr. Ricardo Fernandes (Medical Oncology), Dr. Vikram Velker (Radiation Oncology) and Dr. Nicholas Power (Surgical Oncology). Congratulations to all the winners!

  • Grants Awarded

    May 06, 2022
    The following members were awarded grant funding: MITACS Accelerate Grant: Frank Prato, PhD - $60,000 PSI Foundation: Dr. Michael Rieder - $40,000 Stem Cell Network Funding: John Ronald, PhD - $250,000 WE-SPARK Igniting Discovery Grant Program: Dr. Caroline Hamm - $150,000 Breast Cancer Society of Canada Funding: Lisa Porter, PhD and Dr. Caroline Hamm - $25,000 Dr. Karen Mann Catalyst Grant in Medical Education Research: Dr. Timothy Nguyen

  • CTCR Recruiting New Members

    May 05, 2022
    The CTCR has added the following members to its fold: Kun Ping Lu, PhD (Biochemistry), Xiao Zhen Zhou, PhD (PaLM), Dr. Lucas Mendez (Oncology), Dr. Sara Kuruvilla (Oncology), Elizabeth Huynh, PhD (Oncology), and John Patrick (Oncology). Welcome.

  • WOO Trial Funding Announced

    May 04, 2022
    Ontario Institute for Cancer Research (OICR) announced that Dr. Daniel Breadner, Medical Oncologist will be receiving $247,900 in grant monies as part of its Clinical Translation Pathway Window of Opportunity (WOO) Trial Funding Opportunity. Congratulations.

  • AMOSO Grant Recipients Announced

    May 03, 2022
    Member, Dr Terry Zwiep (Surgery) was awarded an AMOSO Grant (Spring 2022) for his research entitled "Improving the Treatment of Pre-operative Anemia in Colorectal and Hepatopancreato-biliary Patients: A Quality Improvement Initiative".

  • Member named Director, Research Infrastructure

    May 02, 2022
    David Litchfield, PhD, Department of Biochemistry, has been named Director, Research Infrastructure, Schulich School of Medicine & Dentistry, Western University for a three-year term. This new position is crucial to our school's research enterprise and will play a pivotal role implementing our new five-year Strategic Plan.

  • Member Added to the Ranks

    April 20, 2022
    Today, we welcome Mike Hallett, PhD. as a member of the Centre for Translational Cancer Research. Dr. Mike Hallett joined Western University April 1 as a Professor & Western Research Chair - Bioinformatics, Department of Biochemistry. Dr. Hallett was most recently a CRC Tier 1 Professor in the Department of Biology at Concordia University. Most of his career however was in the Departments of Computer Science and Biochemistry at McGill University where he also served as the Director for the Centre for Bioinformatics. Dr. Hallett received his PhD in computer science at the University of Victoria and completed postdoc training at ETH Zurich University. His research interest lie in markers of patient benefit from radiation therapy for in situ breast cancer. Causal networks underlying breast cancer subtype differentiation and systems approaches to the construction of probabilistic biomarkers panels. Welcome Mike!

  • New Member Added

    April 19, 2022
    Today, we welcome Vanessa Dumeaux, Pharma, PhD. as a member of the Centre for Translational Cancer Research. Vanessa Dumeaux joined Western University April 1 as an assistant professor, Department of Anatomy and Cell Biology, Schulich School of Medicine & Dentistry, Western University. Dr. Dumeaux received her doctorate (pharmacy) in France. She then obtained her PhD. in molecular epidemiology, a joint degree from the University of Tromso (Norway) and the University of Paris-South XI (France). During her studies, she developed expertise in genomics while working with Professor Borrensen-Dale at the Norwegian Radium Hospital which was among the pioneers in expression profiling of breast carcinomas in collaboration with groups with Stanford University. After her PhD, Vanessa worked in labs at the University of Paris Descartes, Princeton University, McGill and Concordia Universities. Dr. Dumeaux has a long standing interest in the development of RNA-based biomarker signatures in blood, which can be used to predict disease progression and response to therapy. Welcome Vanessa!

  • New Member Added to the Ranks

    April 18, 2022
    Today, we welcome Jeremy P. Burton, BSc, MSc, PhD. (Otago), dBA as a member of the Centre for Translational Cancer Research. Dr. Burton is a scientist within the Division of Urology in the Department of Surgery and is cross appointed to the Department of Microbiology & Immunology, Schulich School of Medicine & Dentistry, Western University. as an associate professor. He is also the Chair, Human Microbiome and Probiotics; Director, Canadian Centre for Human Microbiome and Probiotics and Scientist, Lawson Health Research Institute, St. Joseph's Hospital. Dr. Burton's research interest include; how the microbiome influences urological conditions (kidney stones, cancer, infection and overactive bladder) and what impacts the microbiota, such as diet, pharmaceuticals, biomaterials, fermented food, probiotics, fecal transplant treatment and the use of antibiotics. Welcome Jeremy!

  • Member named Distinguished University Professor

    April 18, 2022
    Dr. Lisa Porter is the Executive Director of WE-SPARK Health Institute and a Professor in the Department of Biomedical Sciences at the University of Windsor and has achieved the rank of Distinguished University Professor. Dr. Porter completed her PhD at the McMaster University, Hamilton, ON in the Department of Medical Sciences and was a Postdoctoral Fellow at the University of California San Diego, La Jolla, CA. She obtained her B.Sc., Honours Biology & Pharmacology (Co-op program) at McMaster University. She was a founding member of the Windsor Cancer Research Group and continues to sit on the Executive Committee. Dr. Porter is a Canadian Institutes of Health Research (CIHR) University Delegate, a member of the College of Reviewers and a Scientific member of the Barbara Ann Karmanos Tumour and Microenvironment Program. Congratulations Dr. Porter!

  • CTCR Welcomes New Member

    April 15, 2022
    Today, we welcome Douglas Hoover, PhD. MCCPM as a member of the Centre for Translational Cancer Research. Doug is an assistant professor in the Department of Oncology, Schulich School of Medicine & Dentistry, and Department of Medical Biophysics, Western University. Doug is also a medical physicist who specializes in brachytherapy and external beam radiation therapy at the London Regional Cancer Program. London Health Sciences Centre. Doug's research specializes in prostate and lung cancer disease sites. He was recently awarded an LHSC Academic Realignment Initiative Award in the Clinician Scientist category for "Development and clinical integration of artificial intelligence tools to improve quality and efficiency in prostate brachytherapy". Welcome Doug!

  • NSERC Research Grant Recipients

    April 01, 2022

  • LHSC's Academic Realignment Initiative Awards Announced

    April 01, 2022
    London Health Sciences Centre (LHSC), London Health Sciences Foundation (LHSC) and Children's Health Foundation recently announced the recipients of LHSC's Academic Realignment Initiative Awards. The partnership between the two Foundations and LHSC's research institute will support 22 research and quality improvement initiatives. Congratulations to Dr. Bekim Sadikovic, Professor and Program Head, Molecular Diagnostics Program, Department of Pathology and Laboratory Medicine for being named limited term chair for his research on epigenetic mechanisms. This limited term chair position will drive advanced clinical genomic and epigenomic research while simultaneously developing translational pathways for its integreation into patient care. Congratulations on behalf of the CTCR Management Committee and its membership.

  • 2022 Western University Faculty Scholars Award

    March 18, 2022
    Congratulations to Natalie Berube, PhD on her recent Faculty Scholars Award. Established in 2005, the Faculty Scholars Award recognizes significant recent scholarly achievements in teaching or research. Nominated by faculty deans and selected by the Faculty Selection Committee chaired by the Provost, the recipients have an international presence in their discipline and are considered all-round scholars. Winners hold the title "Faculty Scholar" for two years and receive $7,000 each year for scholarly activities, as well as receiving a citation. Congratulations Dr. Berube.

  • Member to serve on LHSC's Medical Advisory Committee

    March 03, 2022
    Dr. Robert Dinniwell, former Radiation Oncology Chair/Chief to serve as interim Chair on London's Health Sciences Centre Medical Advisory Committee. Dr. Dinniwell's is also a former member of CTCR's Management Committee and remains an active member.

  • AMOSO Grants Awarded

    February 24, 2022
    Academic Medical Organization of Southwestern Ontario (AMOSO) recently announced it 2022 funding. Dr. Timothy Nguyen, Radiation Oncologist with London Regional Cancer Centre to receive $150,000 over 2-years to study "Ablative Radiotherapy to Restrain Every Metastasis Safely Treatable (ARREST) 2: A Randomized Phase 2 Trial".

  • New Research Project Targets Metastatic Cancers

    February 23, 2022
    A new project by Alison Allan, PhD recently awarded CCS Challenge Grant as it has the potential to change the future of metastatic cancer. This project will investigate whether a series of simple blood tests can identify how far cancer has spread in a person with metastatic disease. If successful, the test could help guide treatment plans that could improve outcomes for people facing metastatic cancer.

  • Member to collaborate on CFI John R. Evans Leaders Fund (JELF) project

    February 23, 2022
    Dr. Samuel Asfaha, Assistant Professor, Departments of Medicine, and Oncology is a collaborator on a recently announced funded project. Dr. Tom Appleton, Departments of Medicine, and Physiology and Pharmacology along with Dr. Geoffrey Pickering, Departments of Medicine, Biochemistry, and Medical Biophysics are the PI's on the recently announced Canada Foundation for Innovation (CFI) John R. Evans Leaders Fund (JELF).

  • Members named CIHR Award Recipient

    February 15, 2022
    Four members of the CTCR were named CIHR recipients. Dr. Richard Kim, Professor Department of Clinical Pharmacology, Chair of the Division and Wolfe Medical Research Chair has been awarded a CIHR project funding for his new research on breast cancer ($657,900 over 5-years). Dr. Qi Zhang, Assistant Professor, Department of Pathology & Laboratory Medicine, is a collaborator on a project led by Dr. Corey Baron who has also been named in the list of funded projects ($581,400 over 5-years). Gregory Dekaban, PhD and John Ronald, PhD. will also receive funding of $100,000 over 1-year for their research project with Lauren Flynn, PhD. and Dr. Aaron Grant.

  • Lawson Internal Research Fund (Fall of 2021)

    February 01, 2022
    Frank Prato, PhD. and Jonathan Thiessen, PhD. both awarded a Lawson Internal Research Grant for their respective research projects.

  • Dr. Michael Rieder named Fellow

    February 01, 2022
    Dr. Michael Rieder, Professor, Department of Paediatric, Physiology & Pharmacology, Medicine at Schulich School of Medicine and Dentistry, Western University named a Fellow by the British Pharmacological Society for his contributions to pharmacology research.

  • Dr. David Palma in the news

    January 24, 2022
    Dr. David Palma talks about ORATOR, the first published trial comparing quality of life outcomes between treatment options for cancers of the throat and back of the tongue in Ontario Institute for Cancer Research latest newsletter.

  • Lawson places eighth place

    January 19, 2022